Consensus CSX Corporation

Equities

CSX

US1264081035

Market Closed - Nasdaq 04:30:00 2024-03-18 pm EDT 5-day change 1st Jan Change
37.31 USD +0.92% Intraday chart for CSX Corporation -1.92% +7.61%

Evolution of the average Target Price on CSX Corporation

Price target over the last 5 years

History of analyst recommendation changes

65b9bd87bfda7ceba11db403660.un1uwvuyzokRkhPJH7Ifg-JYbP-Xa_BGe0j9asqMSkA.9U4-sb2f-ONn1iTwfoJm4IsMJajSMZUjFTKcJJLOcijgCC_3usr5_n6gWg~5bf8f6e8cacbb3a979f336c3d04eebc4
ANALYST RECOMMENDATIONS : Abbvie, Microsoft, Tesla, Alphabet, Booking... Our Logo
UBS Adjusts CSX Price Target to $40 From $37, Maintains Buy Rating MT
BMO Capital Adjusts Price Target on CSX to $38 From $37, Maintains Outperform Rating MT
Raymond James Adjusts Price Target on CSX to $38 From $35, Keeps Outperform Rating MT
Susquehanna Upgrades CSX to Positive From Neutral, Raises Price Target to $42 From $35 MT
JPMorgan Trims Price Target on CSX to $39 From $40, Maintains Overweight Rating MT
Goldman Sachs Adjusts Price Target on CSX to $38 From $37, Maintains Buy Rating MT
RBC Trims Price Target on CSX to $34 From $35, Keeps Sector Perform Rating MT
Rose-colored glasses are back Our Logo
JPMorgan Upgrades CSX to Overweight From Neutral, Raises Price Target to $40 From $37 MT
ANALYST RECOMMENDATIONS : BAE Systems, Hubspot, Intercontinental, Nasdaq, Netflix... Our Logo
Goldman Sachs Cuts Price Target on CSX to $37 From $39, Keeps Buy Rating MT
ANALYST RECOMMENDATIONS : 3M, Amgen, Eli Lilly, PepsiCo, Charles Schwabb... Our Logo
ANALYST RECOMMENDATIONS : Biogen, Glencore, Home Depot, Meta Platforms, On Semi... Our Logo
Barclays Adjusts CSX Price Target to $40 From $38, Maintains Overweight Rating MT
BofA Securities Upgrades CSX to Buy From Neutral, Raises Price Target to $36 From $34 MT
ANALYST RECOMMENDATIONS : American Express, Biogen, Tesco, Eli Lilly, Oracle... Our Logo
Goldman Sachs Adjusts Price Target on CSX to $39 From $38, Maintains Buy Rating MT
RBC Downgrades CSX to Sector Perform From Outperform, Keeps Price Target at $35 MT
Argus Research Adjusts CSX Price Target to $37 From $35, Maintains Buy Rating MT
JPMorgan Raises CSX's Price Target to $37 From $35, Maintains Neutral Rating MT
Citigroup Trims Price Target on CSX to $38 From $39, Maintains Buy Rating MT
Susquehanna Adjusts CSX Price Target to $36 From $38, Maintains Neutral Rating MT
RBC Trims Price Target on CSX to $35 From $36, Notes 'Mixed' Outlook, Maintains Outperform Rating MT
Benchmark Adjusts Price Target on CSX to $37 From $35, Maintains Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
37.31 USD
Average target price
38.66 USD
Spread / Average Target
+3.62%
High Price Target
46 USD
Spread / Highest target
+23.29%
Low Price Target
30 USD
Spread / Lowest Target
-19.59%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CSX Corporation

UBS
BMO Capital
Raymond James
Susquehanna
JPMorgan Chase
Goldman Sachs
RBC Capital Markets
Barclays
BofA Securities
Argus
Citigroup
Benchmark Company
Morgan Stanley
TD Cowen
Stephens Inc.
Atlantic Equities
Vertical Research
Cowen
Credit Suisse
Wells Fargo Securities
Deutsche Bank Securities
Bernstein
Loop Capital
Stifel Nicolaus
Benchmark Capital
Evercore ISI
TD Securities
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings